These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30082147)

  • 1. Antimalarial Transmission-Blocking Interventions: Past, Present, and Future.
    Delves MJ; Angrisano F; Blagborough AM
    Trends Parasitol; 2018 Sep; 34(9):735-746. PubMed ID: 30082147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium cell biology should inform strategies used in the development of antimalarial transmission-blocking drugs.
    Delves MJ
    Future Med Chem; 2012 Dec; 4(18):2251-63. PubMed ID: 23234549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii.
    Zheng L; Pang W; Qi Z; Luo E; Cui L; Cao Y
    Parasit Vectors; 2016 Aug; 9(1):433. PubMed ID: 27502144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro.
    Sala KA; Nishiura H; Upton LM; Zakutansky SE; Delves MJ; Iyori M; Mizutani M; Sinden RE; Yoshida S; Blagborough AM
    Vaccine; 2015 Jan; 33(3):437-45. PubMed ID: 25454088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines.
    Delves MJ; Ramakrishnan C; Blagborough AM; Leroy D; Wells TN; Sinden RE
    Int J Parasitol; 2012 Oct; 42(11):999-1006. PubMed ID: 23023046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering New Transmission-Blocking Antimalarial Compounds: Challenges and Opportunities.
    Birkholtz LM; Coetzer TL; Mancama D; Leroy D; Alano P
    Trends Parasitol; 2016 Sep; 32(9):669-681. PubMed ID: 27209388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximizing Impact: Can Interventions to Prevent Clinical Malaria Reduce Parasite Transmission?
    McCann RS; Cohee LM; Goupeyou-Youmsi J; Laufer MK
    Trends Parasitol; 2020 Nov; 36(11):906-913. PubMed ID: 32917511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential.
    Liu F; Li L; Zheng W; He Y; Wang Y; Zhu X; Tsuboi T; Cui L; Wang M; Cao Y
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward.
    Nunes JK; Woods C; Carter T; Raphael T; Morin MJ; Diallo D; Leboulleux D; Jain S; Loucq C; Kaslow DC; Birkett AJ
    Vaccine; 2014 Sep; 32(43):5531-9. PubMed ID: 25077422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial transmission-blocking vaccines.
    Sinden RE
    Sci Prog; 1993-1994; 77 ( Pt 1-2)():1-14. PubMed ID: 7801089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the way to eradicating malaria].
    Bastiaens GJ; Bijker EM; Sauerwein RW
    Ned Tijdschr Geneeskd; 2012; 156(5):A4095. PubMed ID: 22296898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taming the Boys for Global Good: Contraceptive Strategy to Stop Malaria Transmission.
    Choi R; Michaels SA; Onu EC; Hulverson MA; Saha A; Coker ME; Weeks JC; Van Voorhis WC; Ojo KK
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32560085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male-Specific Protein Disulphide Isomerase Function is Essential for Plasmodium Transmission and a Vulnerable Target for Intervention.
    Angrisano F; Sala KA; Tapanelli S; Christophides GK; Blagborough AM
    Sci Rep; 2019 Dec; 9(1):18300. PubMed ID: 31797966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosquito-based transmission blocking vaccines for interrupting Plasmodium development.
    Lavazec C; Bourgouin C
    Microbes Infect; 2008 Jul; 10(8):845-9. PubMed ID: 18656409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel model fitted to multiple life stages of malaria for assessing efficacy of transmission-blocking interventions.
    Sherrard-Smith E; Churcher TS; Upton LM; Sala KA; Zakutansky SE; Slater HC; Blagborough AM; Betancourt M
    Malar J; 2017 Apr; 16(1):137. PubMed ID: 28376897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium berghei.
    Zheng W; Kou X; Du Y; Liu F; Yu C; Tsuboi T; Fan Q; Luo E; Cao Y; Cui L
    Vaccine; 2016 May; 34(23):2570-8. PubMed ID: 27083421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine.
    Kou X; Zheng W; Du F; Liu F; Wang M; Fan Q; Cui L; Luo E; Cao Y
    Parasit Vectors; 2016 Apr; 9():190. PubMed ID: 27038925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission blocking malaria vaccines: Assays and candidates in clinical development.
    Sauerwein RW; Bousema T
    Vaccine; 2015 Dec; 33(52):7476-82. PubMed ID: 26409813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate.
    Zheng W; Liu F; He Y; Liu Q; Humphreys GB; Tsuboi T; Fan Q; Luo E; Cao Y; Cui L
    Parasit Vectors; 2017 Jan; 10(1):8. PubMed ID: 28057055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission.
    Wang J; Zheng W; Liu F; Wang Y; He Y; Zheng L; Fan Q; Luo E; Cao Y; Cui L
    Malar J; 2017 Nov; 16(1):458. PubMed ID: 29132428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.